The POLARstar OPTIMA is a full multimode microplate reader which incorporates Simultaneous Dual Emission detection for fluorescent polarization. The POLARstar OPTIMA offers five different measurement principles:
• Fluorescence Polarization • Fluorescence Intensity - including FRET • Time-Resolved Fluorescence - including DELFIA® • High-Performance Luminescence (flash and glow)- including BRET • Absorbance - UV/Vis with path length correction
The POLARstar OPTIMA is designed for the widest possible range of non-radioactive labeled applications:
• Ca2+ Measurements (e.g. Ca2+Flux with Fura-2 or Indo-1) • Molecular Interactions • Enzyme Activity • Cell Toxicity, Proliferation and Viability • ATP Quantification • Immunoassays • Kinase, cAMP, and other second messenger signaling • DNA/RNA quantification • GFP and other fluorescent protein cell-based assays • And many more…
The POLARstar OPTIMA is a multimode microplate reader that covers the wavelength range from 240 – 740 nm (900 nm optional). The POLARstar OPTIMA reads all plate formats from 6- up to 384-well. Top and bottom reading are standard, and the dual-channel detection system can be used for fluorescence polarization as well as dual emission wavelength measurements like FRET or BRET. Incubation up to 45°C or 60°C, gas vent connection, up to two built-in reagent injectors, fast filter wheels, and the ability to define up to 8 sets of filters are just some of the outstanding features found in the POLARstar OPTIMA.
Complete Software Package The POLARstar OPTIMA comes with BMG LABTECH's established OPTIMA Reader Control Software and comprehensive MARS Data Analysis Software. The familiar and highly visual OPTIMA reader control software provides limitless possibilities for test set up and is fully compliant with FDA regulation 21 CFR Part 11. The well-organized Data Analysis Software – MARS – offers a Template Manager for building complex data processing protocols and a Wizard-guided interface to create easy step-by-step calculations, and much more.
‘Smelling’ Prostate Cancer A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.Criminal Justice Alcohol Program Linked to Decreased Mortality Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.Charting Kidney Cancer Metabolism Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.Individuals' Medical Histories Predicted by their Noncoding Genomes Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.'Molecular Movie' Opens Door to New Cancer Treatments An international team of scientists led by the University of Liverpool has produced a 'structural movie' revealing the step-by-step creation of an important naturally occurring chemical in the body that plays a role in some cancers.Advancing Synthetic Biology Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.Preparing for Potential Zika Outbreaks Experts at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection. What do Banana Peels and Human Skin Have in Common? Human skin and banana peels have something in common: they produce the same enzyme when attacked. By studying fruit, researchers have come up with an accurate method for diagnosing the stages of this form of skin cancer. Biomarker for Recurring HPV-Linked Oropharyngeal Cancers A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University. Counting Cancer-busting Oxygen Molecules Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.